<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="50114">Estrogens</z:chebi> are potent neuroprotective compounds in a variety of animal and cell culture models, and data indicate that <z:chebi fb="0" ids="50114">estrogen</z:chebi> receptor (ER)-mediated gene transcription is not required for some of these effects </plain></SENT>
<SENT sid="1" pm="."><plain>To further address the requirement for an ER in <z:chebi fb="0" ids="50114">estrogen</z:chebi> enhancement of neuronal survival, we assessed the enantiomer of <z:chebi fb="0" ids="16469">17beta-estradiol</z:chebi> (ENT-E(2)), which has identical chemical properties but interacts only weakly with known ERs, for neuroprotective efficacy </plain></SENT>
<SENT sid="2" pm="."><plain>ENT-E(2) was both as potent and efficacious as <z:chebi fb="0" ids="16469">17beta-estradiol</z:chebi> in attenuating <z:mp ids='MP_0003674'>oxidative stress</z:mp>-induced <z:hpo ids='HP_0011420'>death</z:hpo> in HT-22 cells, a murine hippocampal cell line </plain></SENT>
<SENT sid="3" pm="."><plain>Further, ENT-E(2) completely attenuated <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> toxicity in human SK-N-SH <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> cells at a 10 nM concentration </plain></SENT>
<SENT sid="4" pm="."><plain>In a <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent model</z:e> of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:chebi fb="0" ids="16469">17beta-estradiol</z:chebi> (100 microgram/kg) or ENT-E(2) (100 microgram/kg), injected 2 h before middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, resulted in a 60 and 61% reduction in lesion volume, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>ENT-E(2), at the doses effective in this study, did not stimulate uterine growth or vaginal opening in juvenile female rats when administered daily for 3 days </plain></SENT>
<SENT sid="6" pm="."><plain>These data indicate that the neuroprotective effects of <z:chebi fb="1" ids="50114">estrogens</z:chebi>, both in vitro and in vivo, can be disassociated from the peripheral estrogenic actions </plain></SENT>
</text></document>